Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft
- 1 January 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (2) , 257-266
- https://doi.org/10.1016/0006-2952(94)90015-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990
- The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecificBiochemical Pharmacology, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- The effect of verapamil on the pharmacokinetics of adriamycinCancer Chemotherapy and Pharmacology, 1986
- The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious ratBritish Journal of Pharmacology, 1986
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985
- Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cellsBritish Journal of Cancer, 1984